Drug Profile
Lazuvapagon - Sanwa Kagaku Kenkyusho
Alternative Names: KRP-N118; SK-1404Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Sanwa Kagaku Kenkyusho
- Class Amides; Antidiuretics; Benzazepines; Pyrazoles; Small molecules
- Mechanism of Action Vasopressin V2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Nocturia
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Nocturia(In volunteers) in United Kingdom (PO)
- 19 Sep 2018 Kyorin Pharmaceutical in collaboration with Sanwa Kagaku Kenkyusho plans a phase II trial for Nocturia in Japan , (JapicCTI-184102)
- 01 Sep 2018 Kyorin Pharmaceutical in collaboration with Sanwa Kagaku Kenkyush initiates enrolment in a phase II trial in Nocturia in Japan (PO) (JapicCTI184102)